Finance

Results: 29809-29820 of 39900

DeFi Technologies Subsidiary Valour Inc. Announces Rebalancing of the Valour Digital Asset Basket 10 (VDAB10) to Include Toncoin and Shiba Inu Coin

FINOS launches AI Readiness as the cornerstone effort of an industry-wide open-source AI initiative for Financial Services.

Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition

Xi's visits to European countries promote healthy, stable China-EU relations

Silver Tiger Intersects 32.0 Meters of 1.36 G/T Gold Equivalent Within 81.1 Meters of 0.94 G/T Gold Equivalent in the Stockwork Zone

Real Chemistry Introduces Iris: An Insights-as-a-Service Platform Delivering Timely Insights on the Obesity Market and the Growing Influence of GLP-1 Therapies

PR Newswire associated0

EIT Food's Accelerator Network programme welcomes its 2024 cohort of fifty ground-breaking European and eight Brazilian startups, bringing cutting edge technology and science together to transform our food system

PR Newswire associated0

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

General Mills today announced it has completed the acquisition of Edgard & Cooper, one of Europe’s leading independent premium pet food brands. Established in 2016, Edgard & Cooper is one of the fastest-growing and most-recognized independent pet food companies in Europe, with estimated 2023 retail sales of more than €100 million across 13 markets. With this transaction, General Mills further advances its Accelerate strategy, including the prioritization of its core markets, global platforms and local gem brands to drive sustainable, profitable growth and top-tier shareholder returns over the long term. (Photo: Business Wire)

General Mills Advances Accelerate Strategy and Expands Pet Food Portfolio with Acquisition of Edgard & Cooper

OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Lions are truly the kings and queens of safari, new Audley Travel research finds

(Graphic: Business Wire)

Piedmont Lithium Announces Q1’24 North American Lithium Production Results